Biospecifix is a niche healthcare firm that focuses on provision of specialty products and services to the Haematology and Flow Cytometry segments of Clinical Pathology (also known as In Vitro Diagnostics or IVD).
Based in Melbourne Biospecifix was established in 2003 by Terry Fawcett to initially provide specialised consulting services including market research and competitive intelligence in Haematology and associated IVD segments. In 2010 Biospecifix began to distribute specialty flow cytometry reagents and controls to the Australasian (Australia and New Zealand) clinical pathology and research markets.
Biospecifix is recognised in the industry for providing outstanding customer service, high quality flow cytometry and haematology products and support.
The distribution arm of the Biospecifix business has grown rapidly with Biospecifix now supplying in addition to Flow Cytometry reagents and controls specific Haematology Rapid Diagnostic Test kits (RDT) for Malaria and Thalassaemia detection.
In 2015 Biospecifix expanded the RDT business beyond Australasia to include The Solomons Islands where Malaria is endemic. Also in 2015 Steve Valentine, ex Austin Hospital Melbourne, joined Biospecifix to provide specialty flow cytometry support for Australasian clients.
In 2016 Biospecifix obtained exclusive rights to the Thalassaemia RDT products for Hong Kong and is also collaborating with an established Chinese Healthcare conglomerate to provide these kits into mainland China.
In 2017 Biospecifix continued its growth announcing the signing of a distribution agreement with CellaVision - the worlds leading digital morphology supplier in Haematology.
Today Biospecifix has two arms of its business running successfully – a rapidly growing distribution arm where niche Haematology and Flow Cytometry instruments and reagents are sold in Australasia, Hong Kong and the Asia Pacific and a consulting arm which undertakes specific projects for local and global healthcare organizations.
Email: firstname.lastname@example.org Tel: +61 3 9899 3668
Terry Fawcett is the owner and Managing Director of Biospecifix. He has a Medical Science Degree from RMIT University (1980) with qualifications in Haematology and Blood Banking and Post Graduate marketing qualifications from Monash University obtained in 1992.
Terry began his career in Medical Laboratory Science in 1973 in the Haematology Department at the Alfred Hospital. He has over 40 years experience in the Laboratory Haematology industry including senior laboratory management roles at the Alfred and Royal Melbourne Hospitals in Melbourne. Terry has also worked for large global companies such as Beckman Coulter and Sysmex (via their distributor Australian Diagnostics Corporation) in marketing and sales roles. He also consulted to a number of the leading global Laboratory Haematology companies on specific projects from 1995 to 2005.From 2006-2009 Terry was appointed as consultant CEO for the Spinal Cord Society of Australia (now StepAhead Australia).Between 2000 and 2014 Terry looked after membership and marketing for International Society of Laboratory Haematology (ISLH) and was instrumental in the growth and development of that organization. Since 2014 Terry has looked after the administration of the International Council for Standardization in Haematology (ICSH) and liaises with the board headed by Professor Sam Machin to fulfil its charter – this includes organization of the annual ICSH General Assembly. He has a very well established network of global and local contacts and thought leaders in Haematology, Haemostasis and Flow Cytometry which assists in delivering value for his clients.
Today Biospecifix has two arms of its business running successfully – a rapidly growing distribution arm where niche Haematology and Flow Cytometry reagents are sold in Australasia, Hong Kong and Asia Pacific and a consulting arm which undertakes specific projects for local and global organizations.
HAEMATOLOGY BUSINESS MANAGER
Email: email@example.com Tel: +61 3 9899 3668
Damien Heathcote is the Haematology Business Manager for Biospecifix. Damien holds both Bachelor and Masters Degrees in Medical Laboratory Science and has spent over 30 years in the Haematology and Blood Transfusion fields.He has over 10 years corporate experience with both CSL and Haemonetics, and has also completed a Graduate Diploma in Corporate Management.
Damien is a Fellow in Haematology with the Australian Institute of Medical Scientists and after gaining this qualification in 1992 spent 14 years lecturing in Haematology and Blood Transfusion at the University of Tasmania. Damien is passionate about using technology to improve laboratory practice and to benefit patient care and is really excited to be providing digital haematology morphology solutions to the Australasian Pathology Industry.
Email: firstname.lastname@example.org Tel: +61 3 9899 3668
PRODUCT APPLICATIONS SPECIALIST
Steve Valentine is an experienced Senior Scientist based in Melbourne and began his medical science career at Dr Dorevitch Pathology in the early 80s in the Haematology lab. He then subsequently was in Charge of the Blood Bank. From there he moved to the National Blood Group Reference Laboratory at CSL in 1986 to develop his special interest in Immunohaematology.
In 1988 Steve moved to the Heidelberg Repatriation Hospital, a major Teaching Hospital in Eastern suburbs of Melbourne, completing his Fellowship by examination in Blood Banking in 1991. In 1995 he moved to the newly amalgamated Austin Hospital Laboratory and took on various roles - initially in the Blood Bank and then in Charge of Haematology, followed by Manager of the satellite laboratories at Repatriation Hospital and the Latrobe University Medical Centre. In 1999 he recalled to the Central Lab to manage Specimen Reception.
With the co-location of the Austin Hospital with the Mercy Hospital for Women in 2005 came opportunity for Steve to work in the Immunology laboratory where he was responsible for thalassaemia and haemoglobinopathy screening and general Flow Cytometry. In 2012 he was appointed in Charge of the Immunology Laboratory, which encompassed routine Flow Cytometry, Autoantibody Screening tests (IF and ELISA) and Peripheral Blood Stem Cell Cryopreservation Services.
Over the course of his career Steve has been very active in professional circles, presenting regularly at local Special Interest Group Meetings and at National Scientific Meetings. He was Convener of the local Haematology Meetings in Melbourne from 2007 to 2012. He has also been working concurrently at RMIT since the early '90s - as a demonstrator, lecturer, tutor and more recently as a manager of student projects. For these long-standing contributions Steve was awarded the George Swanson Christie Award from the Australian Institute of Medical Scientists in 2014.
In summary, Steve has an extensive experience of work in major Public Hospital Laboratories - from 'front end' processing and re-engineering, through routine testing, emergency services and specialty testing services such as those for Leukaemia and Lymphoma diagnosis. He has worked
with many different technologies, instrument platforms and Laboratory Information Systems. He has had the great privilege of working with some innovative and leading Scientists and Consultants along the way.
In October 2014 Steve joined Biospecifix in the role of Product Applications Specialist. The products he helps promote and support include best of breed reagents and kits in Haematology and Flow Cytometry. Steve’s major focus at Biospecifix is Flow Cytometry, in particular managing the Company’s association with Cytognos, Infinicyt and Euroflow.
"We understand the value of providing the best customer service and delivering at all times with you the customer as the focus. Our business philosophy is simple – excellent products, excellent service."
DISTRIBUTORS YOU CAN TRUST
WE PRIDE OURSELVES ON RESPONDING RAPIDLY TO ALL INQUIRIES AND ORDERS
WE LIKE TO PARTNER WITH OUR CLIENTS AND ADDRESS THEIR NEEDS
WE RESPOND RAPIDLY AS OUR CLIENTS DESERVE AND HAVE COME TO EXPECT